EXO EXOR N.V.

Exor Press Release - Periodic Report on the Buyback Program

Exor Press Release - Periodic Report on the Buyback Program

Amsterdam, 1 July 2024

EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the first tranche of the share buyback program of up to €125 million announced on 15 April 2024 (the “first tranche”), the Company has completed the following transactions on Euronext Amsterdam, CBOE DXE and Turquoise Europe:

EURONEXT AMSTERDAM

Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees (€)Total consideration excluding fees (€)
24 June 202422,13598.882,188,790.70
25 June 202422,84599.412,271,108.26
26 June 202422,84099.532,273,310.88
27 June 202423,36298.802,308,088.51
28 June 202410,22598.311,005,260.65
TOTAL101,407 10,046,559.00

CBOE DXE

Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees (€)Total consideration excluding fees (€)
24 June 202412,17698.891,204,061.51
25 June 202410,38499.401,032,128.06
26 June 202410,68399.531,063,285.40
27 June 202410,31998.801,019,530.61
28 June 20244,19398.34412,327.46
TOTAL47,755 4,731,333.04

TURQUOISE EUROPE

Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees (€)Total consideration excluding fees (€)
24 June 202498498.0596,485.33
25 June 20241,04899.57104,348.10
26 June 20241,04399.57103,856.10
27 June 20241,11299.65110,810.80
28 June 202475998.6274,849.70
TOTAL4,946  490,350.03



After these purchases, the total invested amount under the first tranche is approximately €125 million for a total amount of 1,242,623 ordinary shares purchased.

With the purchases described above the Company has completed the first tranche of the share buyback program announced on 15 April 2024 which was a restart of the buyback program announced on 13 September 2023.



As of 1 July 2024, the Company held in total 6,140,167 ordinary shares in treasury (2.78% of total ordinary issued share capital)1.

A comprehensive overview of the transactions carried out under the share buyback program, as well as the details of the above transactions, are available on Exor’s corporate website under the .



1 This corresponds to 0.85% of the total issued share capital including both ordinary shares and special voting shares.

Attachment



EN
01/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EXOR N.V.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Akzo Nobel: FX drives 2Q25 miss and FY guidance cut. dsm-firmenich: Givaudan 1H25 results. Exor: In talks over Iveco sale. Lotus Bakeries: Peer Lindt & Sprüngli 1H25 results. Proximus: CpaaS peer Sinch 2Q25 results hurt by FX. Signify: 2Q25 Preview, challenges ahead. Var Energi: Promising continuation of dividend. Vopak: Continued story. Wereldhave: Strong operational results, positive market tone, guidance raised. Events Calendar

Hilde Van Boxstael ... (+5)
  • Hilde Van Boxstael
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Wim Hoste
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aalberts: First hydronic flow control takeover in US; Ahold Delhaize: Preview 2Q25; EVS: Wins 2026 world cup contract Big Event Rental; Exor: A tad more Philips; Via Transportation reviving IPO plans; Heijmans: 1H25 preview; looks to be on track; KPN: 2Q25 preview; Montea: €24m acquisition in Dutch logistics hotspot; Ontex: Peer Essity 2Q25 results; RELX: 1H25 preview; Sligro: Weak 1H25 calls for 7.5% downgrade to consensus at EBITDA level; Events Calendar

Hilde Van Boxstael ... (+5)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

D'Ieteren: Belron renegotiating US$4.65bn TLB debt at lower rates Exor: Call for caution, also after tax probe settlement Solvay: Cuts 2025F EBITDA outlook, maintains FCF guidance TomTom: 2Q25 results; guidance increased

ResearchPool Subscriptions

Get the most out of your insights

Get in touch